Insight Molecular Diagnostics (0KCC) Income Statement
Insight Molecular Diagnostics Income Statement
Last quarter (Q2 2026), Insight Molecular Diagnostics's total revenue was $239.00K, a decrease of 53.86% from the same quarter last year. In Q2, Insight Molecular Diagnostics's net income was $-11.26M. See Insight Molecular Diagnostics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| $ 4.05M | $ 1.88M | $ 1.50M | $ 958.00K | $ 2.20M | |
| $ 190.00K | $ 740.00K | $ 413.00K | $ -18.00K | $ 1.42M | |
| $ 30.77M | $ 61.78M | $ 25.55M | $ 17.98M | $ 55.15M | |
| Depreciation and Amortization | $ 2.20M | $ 1.56M | $ 1.68M | $ 5.22M | $ 4.21M |
| $ -47.92M | $ -59.02M | $ -23.12M | $ -13.31M | $ -48.46M | |
| $ -30.58M | $ -61.04M | $ -25.14M | $ -18.00M | $ -53.73M | |
| $ -19.64M | $ 378.00K | $ 281.00K | $ -615.00K | $ 854.00K | |
| $ -50.22M | $ -60.66M | $ -24.86M | $ -18.61M | $ -52.87M | |
| $ -50.22M | $ -60.66M | $ -27.78M | $ -72.90M | $ -64.10M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.65 | $ -4.66 | $ -3.75 | $ -20.00 | $ -14.40 |
| Diluted EPS | $ -1.65 | $ -4.66 | $ -3.75 | $ -20.00 | $ -14.40 |
| Weighted Average Shares Outstanding | 30.48M | 13.07M | 7.65M | 5.54M | 4.45M |
| Weighted Average Shares Outstanding (Diluted) | 30.48M | 13.07M | 7.65M | 5.54M | 4.45M |
Currency in USD